The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.
Open accessAbstract
Injection of mineral oils such as pristane into the peritoneal cavities of BALB/c mice results in a chronic peritonitis associated with high tissue levels of interleukin 6 (IL-6). Here we show that increased prostaglandin E2 (PGE2) synthesis causes induction of IL-6 and that expression of an inducible cyclooxygenase, Cox-2, may mediate this process. Levels of both PGE2 and IL-6 are elevated in inflammatory exudates from pristane-treated mice compared with lavage samples from untreated mice. The Cox-2 gene is induced in the peritoneal macrophage fraction isolated from the mice. A cause and effect relationship between increased macrophage PGE2 and IL-6 production is shown in vitro. When peritoneal macrophages are activated with an inflammatory stimulus (polymerized albumin), the Cox-2 gene is induced and secretion of PGE2 and IL-6 increases, with elevated PGE2 appearing before IL-6. Cotreatment with 1 microM indomethacin inhibits PGE2 production by the cells and reduces the induction of IL-6 mRNA but has no effect on Cox-2 mRNA, consistent with the fact that the drug inhibits catalytic activity of the cyclooxygenase but does not affect expression of the gene. Addition of exogenous PGE2 to macrophages induces IL-6 protein and mRNA synthesis, indicating that the eicosanoid stimulates IL-6 production at the level of gene expression. PGE2-stimulated IL-6 production is unaffected by addition of indomethacin. Taken together with the earlier finding that indomethacin diminishes the elevation of IL-6 in pristane-treated mice, the results show that PGE2 can induce IL-6 production in vivo and implicate expression of the Cox-2 gene in the regulation of this cytokine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Hla, T., & Neilson, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7384 · Cited by 1,465
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Akira, S., Hirano, T., Taga, T., & Kishimoto, T. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199284 · Cited by 1,306
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
van Deventer, S., Buller, H., ten Cate, J., Aarden, L., Hack, C., & Sturk, A. (1990) · Blood · doi:10.1182/blood.v76.12.2520.2520 · Cited by 851
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 826
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35698-9 · Cited by 811
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., & Hla, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117060 · Cited by 655
Molecular Regulation of B Lymphocyte Response
Kishimoto, T., & Hirano, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002413 · Cited by 567
Bataille, R., Jourdan, M., Zhang, X. G., & Klein, B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114392 · Cited by 479
Functional discrimination between interleukin 6 and interleukin 1
Helle, M., And, L. B., & Aarden, L. A. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181010 · Cited by 424
A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro
Nordan, R. P., & Potter, M. (1986) · Science · doi:10.1126/science.3726549 · Cited by 375
Strassmann, G., Patil-Koota, V, Finkelman, F., Fong, M., & Kambayashi, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2365 · Cited by 367
Sano, H., Hla, T., Maier, J. A., Crofford, L. J., Case, J. P., Maciag, T., & Wilder, R. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115591 · Cited by 345
Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
Fong, Y., Moldawer, L. L., Marano, M., Wei, H., Tatter, S. B., Clarick, R. H., Santhanam, U., Sherris, D., May, L. T., Sehgal, P. B., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.7.2321 · Cited by 319
Zhang, Y., Lin, J. X., & Vilcek, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68768-x · Cited by 254
Activated neutrophils induce prolonged DNA damage in neighboring cells
Shacter, E., Beecham, E. J., Covey, J. M., Kohn, K. W., & Potter, M. (1988) · Carcinogenesis · doi:10.1093/carcin/9.12.2297 · Cited by 235
Self-citationHoussiau, F. A., Bukasa, K. S., Sindic, C., Damme, J. V., & Snick, J. V. (1988) · PubMed · Cited by 226
Modes of action of aspirin-like drugs.
Abramson, S., Korchak, H., Ludewig, R., Edelson, H., Haines, K., Levin, R. I., Herman, R., Rider, L., Kimmel, S., & Weissmann, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7227 · Cited by 219
Interleukin-6 and its relation to inflammation and disease
Hirano, T. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90042-m · Cited by 208
Mahida, Y. R., Kurlac, L., Gallagher, A., & Hawkey, C. J. (1991) · Gut · doi:10.1136/gut.32.12.1531 · Cited by 184
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation
Rosen, G. D., Birkenmeier, T. M., Raz, A., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91819-6 · Cited by 152
Potter, M., & Wax, J. S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1591 · Cited by 151
Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein, B., Zhang, X., Jourdan, M., Boiron, J.-M., Portier, M., Lu, Z., Wijdenes, J., Brochier, J., & Bataille, R. (1990) · PubMed · Cited by 122
Vink, A., Coulie, P. G., Warnier, G., Renauld, J., Stevens, M., Donckers, D., & Snick, J. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.3.997 · Cited by 120
Farber, J. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1535-1545.1992 · Cited by 100
Cancro, M. P., & Potter, M. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.144.6.1554 · Cited by 88
Shacter, E. B., Arzadon, G., & Williams, J. A. (1992) · Blood · doi:10.1182/blood.v80.1.194.bloodjournal801194 · Cited by 88
Self-citationShacter, E. B., Lopez, R. L., & Pati, S. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90204-i · Cited by 83
Self-citationInhibition of plasmacytoma development in BALB/c mice by indomethacin.
Potter, M., Wax, J. S., Anderson, A. O., & Nordan, R. P. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.5.996 · Cited by 77
Interleukin 6 in Infection and Cancer
Sehgal, P. B. (1990) · Experimental Biology and Medicine · doi:10.3181/00379727-195-43129d · Cited by 71
Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells.
Leal‐Berumen, I., O’Byrne, P. M., Gupta, A. K., Richards, C. D., & Marshall, J. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4759 · Cited by 67
Bothwell, W. M., Verburg, M. T., Wynalda, M. A., Daniels, E. G., & Fitzpatrick, F. A. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32927-7 · Cited by 59
Taupin, V., Gogusev, J., Descamps‐Latscha, B., & Zavala, F. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13441-x · Cited by 43
Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration
Goss, J. A., Mangino, M. J., Callery, M. P., & Flye, M. W. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.264.4.g601 · Cited by 39
Bunning, R. A. D., Russell, R. G. G., & Damme, J. V. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90988-y · Cited by 38
Interactions between cytokines and eicosanoids: a study using human peritoneal macrophages
Pruimboom, W. M., Dijk, J. P. M. V., Tak, C. A. M., Garrelds, I. M., Bonta, I. L., Wilson, P. J. H., & Zijlstra, F. J. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)90142-2 · Cited by 37
Komatsu, H., Yaju, H., Chiba, K., & Okumoto, T. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90165-4 · Cited by 33
Ogle, C. K., Guo, X., Szczur, K., Hartmann, S., & Ogle, J. D. (1994) · Inflammation · doi:10.1007/bf01534558 · Cited by 31
Takakura, K., Mason, W. B., & Hollander, V. P. (1966) · PubMed · Cited by 25
Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
Seibert, K., Masferrer, J., Zhang, Y., et al. (1995) · PubMed · Cited by 25
Cited by
Chronic inflammation and oxidative stress in human carcinogenesis
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., & Loguercio, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23192 · Cited by 1,001
Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Khansari, N., Shakiba, Y., & Mahmoudi, M. (2009) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221309787158371 · Cited by 921
Bagga, D., Wang, L., Farias-Eisner, R., Glaspy, J. A., & Reddy, S. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334211100 · Cited by 638
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
Quach, H., Ritchie, D., Stewart, A. K., Neeson, P., Harrison, S., Smyth, M. J., & Prince, H. M. (2010) · Leukemia · doi:10.1038/leu.2009.236 · Cited by 600
Regulation of Cytochromes P450 During Inflammation and Infection
Morgan, E. T. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002246 · Cited by 488
Metadata
- Authors
- Hinson, R. M., Williams, J. A., & Shacter, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-05-14
- Volume
- 93
- Issue
- 10
- Pages
- 4885-4890
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2108661128
- Cited by
- 302
- References
- 49
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.